Back to COGT
GOLDMAN SACHS GROUP INC → COGT
GOLDMAN SACHS GROUP INC COGT Position History
Cogent Biosciences, Inc. • Healthcare
Quarters held
18
Latest value
$243K
Q3 2026
Peak value
$155.2M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $7.1M |
| Q2 2025 | $1.5M |
| Q3 2025 | $18.8M |
| Q3 2025 | $5M |
| Q4 2025 | $12.2M |
| Q4 2025 | $48.4M |
| Q4 2025 | $48.4M |
| Q4 2025 | $12.2M |
| Q1 2026 | $155.2M |
| Q1 2026 | $15.4M |
| Q2 2026 | $63.1M |
| Q2 2026 | $25M |
| Q2 2026 | $277K |
| Q2 2026 | $235K |
| Q3 2026 | $52.3M |
| Q3 2026 | $23.3M |
| Q3 2026 | $334K |
| Q3 2026 | $243K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $243K | 7.6K | — | — |
| Q3 2026 | $334K | 10.4K | — | — |
| Q3 2026 | $23.3M | 726.2K | — | — |
| Q3 2026 | $52.3M | 1.63M | — | — |
| Q2 2026 | $235K | 6.1K | — | — |
| Q2 2026 | $277K | 7.2K | — | — |
| Q2 2026 | $25M | 646.1K | — | — |
| Q2 2026 | $63.1M | 1.63M | — | — |
| Q1 2026 | $15.4M | 401.1K | — | — |
| Q1 2026 | $155.2M | 4.03M | — | — |
| Q4 2025 | $12.2M | 343.9K | — | — |
| Q4 2025 | $48.4M | 1.36M | — | — |
| Q4 2025 | $48.4M | 1.36M | — | — |
| Q4 2025 | $12.2M | 343.9K | — | — |
| Q3 2025 | $5M | 349.7K | — | — |
| Q3 2025 | $18.8M | 1.31M | — | — |
| Q2 2025 | $1.5M | 206.3K | — | — |
| Q2 2025 | $7.1M | 994.1K | — | — |
Other funds holding COGT
$868.7M
$808M
$756M
$706.8M